Prof Richard Randall
Professor (Re-engaged)
Research areas
Following infection with a virus the body mounts innate and adaptive (e.g. antibodies) immune response that are critical in controlling the infection. Immediately following infection, cells begin to respond to viruses by producing a substance called interferon (IFN). The IFN system is an extremely powerful anti-viral response that if it worked as it was supposed to could probably control most, if not all, virus infections in the absence of the adaptive immune response. However, it rarely works correctly because all viruses have ways and means of at least partially circumvent the IFN response. Many viruses do so by producing products (usually proteins) that interfere with different parts of the IFN system. We are particular concerned with better understanding at the molecular level how influenza viruses and paramyxoviruses (e.g. mumps, measles, parainfluenza viruses) circumvent the IFN response. Not only are such studies of fundamental interest they may also point ways forward to better methods of controlling virus infections. For example, by knocking out the ability of a virus to circumvent the IFN response the virus will be weakened and unable to cause disease. However, such weakened (attenuated) viruses if injected will induce an adaptive immune response that will protect from subsequent infection by the natural (virulent) viruses. Thus such IFN-sensitive viruses may be further developed as attenuated virus vaccines. Furthermore, novel anti-viral drugs might be developed which prevent viruses from circumventing the IFN response.
Selected publications
-
Open access
Liquid-liquid phase inclusion bodies in acute and persistent parainfluenaza virus type 5 infections
Wignall-Fleming, E. B., Carlos, T. S. & Randall, R. E., 12 Sept 2024, (E-pub ahead of print) In: Journal of General Virology. 105, 9, 12 p., 002021.Research output: Contribution to journal › Article › peer-review
-
Open access
Persistent paramyxovirus infections: in co-infections the parainfluenza virus type 5 persistent phenotype is dominant over the lytic phenotype
Randall, R. E., Young, D. F., Hughes, D. J. & Goodbourn, S., 14 Nov 2023, In: Journal of General Virology. 104, 11, 13 p., 001916.Research output: Contribution to journal › Article › peer-review
-
Open access
The timing and magnitude of the type I interferon response are correlated with disease tolerance in arbovirus infection
Hardy, A., Bakshi, S., Furnon, W., MacLean, O., Gu, Q., Varjak, M., Varela, M., Aziz, M. A., Shaw, A. E., Pinto, R. M., Cameron Ruiz, N., Mullan, C., Taggart, A. E., Da Silva Filipe, A., Randall, R. E., Wilson, S. J., Stewart, M. E. & Palmarini, M., 1 Jun 2023, In: mBio. 14, 3, 20 p., e0010123.Research output: Contribution to journal › Article › peer-review
-
Open access
Organic light-emitting diode based fluorescence-linked immunosorbent assay for SARS-CoV-2 antibody detection
Lian, C., Young, D. F., Randall, R. E. & Samuel, I. D. W., 5 Dec 2022, In: Biosensors. 12, 12, 13 p., 1125.Research output: Contribution to journal › Article › peer-review
-
Open access
Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria
Daza-Cajigal, V., Albuquerque, A. S., Young, D. F., Ciancanelli, M. J., Moulding, D., Angulo, I., Jeanne-Julien, V., Rosain, J., Minskaia, E., Casanova, J.-L., Boisson-Dupuis, S., Bustamante, J., Randall, R. E., McHugh, T. D., Thrasher, A. J. & Burns, S. O., 9 Sept 2022, In: Frontiers in Immunology. 13, 14 p., 888427.Research output: Contribution to journal › Article › peer-review
-
A co-opted ISG15-USP18 binding mechanism normally reserved for deISGylation controls type I IFN signalling
Vasou, A., Nightingale, K., Cetkovska, V., Bamford, C., Andrejeva, J., Randall, R. E., McLauchlan, J., Weekes, M. & Hughes, D. J., 3 Jun 2021, bioRxiv, 38 p.Research output: Working paper › Preprint
-
Open access
Genetic lesions of type I interferon signalling in human antiviral immunity
Duncan, C. J. A., Randall, R. E. & Hambleton, S., Jan 2021, In: Trends in Genetics. 37, 1, p. 46-58 13 p.Research output: Contribution to journal › Review article › peer-review
-
Open access
Direct antiviral activity of interferon stimulated genes is responsible for resistance to paramyxoviruses in ISG15-deficient cells
Holthaus, D., Vasou, A., Bamford, C., Andrejeva, J., Paulus, C., Randall, R. E., McLauchlan, J. & Hughes, D. J., 22 Jun 2020, (E-pub ahead of print) In: The Journal of Immunology. 11 p., ji1901472.Research output: Contribution to journal › Article › peer-review
-
Open access
Innate intracellular antiviral responses restrict the amplification of defective virus genomes of parainfluenza virus type 5
Wignall-Fleming, E. B., Vasou, A., Young, D., Short, J. A. L., Hughes, D. J., Goodbourn, S. & Randall, R. E., 16 Jun 2020, (E-pub ahead of print) In: Journal of Virology. 94, 13, 15 p., 00246-20.Research output: Contribution to journal › Article › peer-review
-
Open access
Analysis of paramyxovirus transcription and replication by high-throughput sequencing
Wignall-Fleming, E. B., Hughes, D. J., Vattipally, S., Modha, S., Goodbourn, S., Davison, A. J. & Randall, R. E., 13 Aug 2019, In: Journal of Virology. 93, 17, 17 p., e00571-19.Research output: Contribution to journal › Article › peer-review